Market closedADR

Adagene/$ADAG

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Adagene

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Ticker

$ADAG
Trading on

Industry

Biotechnology
Headquarters

Employees

174

Adagene Metrics

BasicAdvanced
$97M
Market cap
-
P/E ratio
-$0.72
EPS
0.65
Beta
-
Dividend rate
$97M
0.65
$4.38
$1.35
59K
2.5
2.422
8.26
36.74
-38.43%
-19.59%
-45.70%
118.408
1.72
1.72
-3.393
-96.40%
-15.23%
-22.47%
-33.86%

What the Analysts think about Adagene

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Adagene stock.

Adagene Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Adagene Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ADAG

$

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Adagene stock?

Adagene (ADAG) has a market cap of $97M as of November 25, 2024.

What is the P/E ratio for Adagene stock?

The price to earnings (P/E) ratio for Adagene (ADAG) stock is 0 as of November 25, 2024.

Does Adagene stock pay dividends?

No, Adagene (ADAG) stock does not pay dividends to its shareholders as of November 25, 2024.

When is the next Adagene dividend payment date?

Adagene (ADAG) stock does not pay dividends to its shareholders.

What is the beta indicator for Adagene?

Adagene (ADAG) has a beta rating of 0.65. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.